Scheperjans, Filip

Gut microbiota are related to Parkinson's disease and clinical phenotype

Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 1,968

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease

Aho, V. T. E., Houser, M. C., Pereira, P. A. B., Chang, J., Rudi, K., Paulin, L., Hertzberg, V., Auvinen, P., Tansey, M. G., & Scheperjans, F. (2021) · Molecular Neurodegeneration

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 435

The human inferior parietal lobule in stereotaxic space

Caspers, S., Eickhoff, S. B., Geyer, S., Scheperjans, F., Mohlberg, H., Zilles, K., & Amunts, K. (2008) · Brain Structure and Function

Spatial Neglect and Hemispheric DysfunctionNeural and Behavioral Psychology Studies

Cited by 395

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression

Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 361

More than constipation - Bowel symptoms in Parkinson's disease and their connection to gut microbiota

Mertsalmi, T. H., Aho, V. T. E., Pereira, P. A. B., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2017) · European Journal of Neurology

Gastrointestinal motility and disordersParkinson's Disease Mechanisms and Treatments

Cited by 153

Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial

Scheperjans, F., Levo, R., Bosch, B., Lääperi, M., Pereira, P. A. B., Smolander, O.-P., Aho, V. T. E., Vetkas, N., Toivio, L., Kainulainen, V., et al. (2024) · JAMA Neurology

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 128

Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease

Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2020) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 95

Antibiotic Exposure and Risk of Parkinson's Disease in Finland: A Nationwide Case‐Control Study

Mertsalmi, T. H., Pekkonen, E., & Scheperjans, F. (2020) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 88

Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?

Scheperjans, F., Pekkonen, E., Kaakkola, S., & Auvinen, P. (2015) · Journal of Parkinson’s Disease

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 83

Multiomics Implicate Gut Microbiota in Altered Lipid and Energy Metabolism in Parkinson’s Disease

Pereira, P. A. B., Trivedi, D. K., Silverman, J., Duru, I. C., Paulin, L., Auvinen, P., & Scheperjans, F. (2022) · npj Parkinson s Disease

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 40

Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals

Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A. I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G. W., Brockmann, K., Aho, V. T. E., et al. (2024) · Scientific Reports

Gut microbiota and healthInflammatory Bowel Disease

Cited by 36

Gut Bacterial Tyrosine Decarboxylase Associates with Clinical Variables in a Longitudinal Cohort Study of Parkinsons Disease

van Kessel, S. P., Auvinen, P., Scheperjans, F., & El Aidy, S. (2021) · npj Parkinson s Disease

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 34